Chemists from Scripps Research and the University of California, Los Angeles, have developed methods for the precise, flexible modification of a broad class of chemical compounds called bicyclic ...

Blood disorder therapeutics firm Bioverativ, which was spun out from Biogen earlier this year, announced a research collaboration with Bicycle Therapeutics focused on developing and commercializing ...

The inhibition of pathological protein-protein interactions is a promising approach for treating a large number of diseases, including many forms of cancer. A team of researchers has now developed a ...

BERLIN & CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bayer and Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics by utilizing ...

AstraZeneca will partner with Bicycle Therapeutics to develop respiratory, cardiovascular, and metabolic disease treatments based on Bicycle’s proprietary bicyclic peptide (Bicycle ®) product platform ...

Sequential intravesical gemcitabine and docetaxel versus bacillus Calmette-Guérin for the treatment of high-risk, treatment-naïve, non-muscle invasive bladder cancer. This is an ASCO Meeting Abstract ...

Cytokinetics Inc. has identified bicyclic piperazinones with the ability to modulate skeletal muscle contractility reported to be useful for the treatment of amyotrophic lateral sclerosis, spinal ...

CAMBRIDGE, United Kingdom & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle ® ...

Bicyclic peptides have spurred some multimillion-dollar deals in recent years, as drug developers begin to exploit the peptides’ power to target and bind proteins. Now, researchers led by Christoph ...

Consists of six departments and provides education in the fields of physics, mathematics, chemistry, informatics, biology and ecology, geography and tourism. Almost all courses of study programmes ...